Multi-center evaluation, of the second-generation digene hybrid capture® II HBV test

被引：0
|
作者：
Garcia-Meijide, M
Eddington, N
Brill, J
Niesters, HGM
Kraiden, FE
Cork, M
De Medina, M
Eddington, N
Brill, J
Niesters, HGM
Fries, E
Kraiden, M
Cork, M
De Medina, M
Hill, M
Lörincz, AT
机构：
[1] Digene Corp, Silver Spring, MD USA
[2] Univ Hosp Dijkzigt, Dept Virol, NL-3015 GD Rotterdam, Netherlands
[3] Toronto Hosp, Toronto Med Labs, Toronto, ON M5T 2S8, Canada
[4] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1666
引用
收藏
页码：579A / 579A
页数：1
相关论文
共 50 条
  • [41] Comparison of VERSANT hepatitis B virus DNA 3.0 assay with digene hybrid capture II hepatitis B virus DNA test in relation to clinical status of hepatitis B virus
    Song, Eun Young
    Hur, Mina
    Lee, Kyu Man
    Yun, Yeomin
    Lee, Chang Hoon
    Choi, Young-Sook
    Lee, Kyung-A
    Roh, Eun Youn
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (06): : 451 - 457
  • [42] SCHIZOPHRENIA TREATMENT WITH SECOND-GENERATION ANTIPSYCHOTICS: A MULTI-COUNTRY EVALUATION OF THE COSTS OF CARDIOVASCULAR AND METABOLIC ADVERSE EVENTS AND WEIGHT GAIN
    Kearns, B.
    Cooper, K.
    Cantrell, A.
    VALUE IN HEALTH, 2020, 23 : S605 - S605
  • [43] The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study
    Petersen, Esben Thade
    Mouridsen, Kim
    Golay, Xavier
    NEUROIMAGE, 2010, 49 (01) : 104 - 113
  • [44] Multi-center evaluation of the Emit® II Plus Amphetamines Assay with 300, 500 or 1000 ng/mL cutoffs.
    Romero, LF
    Morjana, N
    CLINICAL CHEMISTRY, 2004, 50 (06) : A135 - A135
  • [45] Improved survivorship of hybrid metal-on-metal hip resurfacing with second-generation techniques for Crowe-I and II developmental dysplasia of the hip
    Amstutz, Harlan C.
    Le Duff, Michel J.
    Harvey, Norah
    Hoberg, Maik
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A : 12 - 20
  • [46] Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study
    Stafford, Kristen A.
    Odafe, Solomon F.
    Lo, Julia
    Ibrahim, Ramat
    Ehoche, Akipu
    Niyang, Mercy
    Aliyu, Gambo G.
    Gobir, Bola
    Onotu, Dennis
    Oladipo, Ademola
    Dalhatu, Ibrahim
    Boyd, Andrew T.
    Ogorry, Otse
    Ismail, Lawal
    Charurat, Manhattan
    Swaminathan, Mahesh
    PLOS ONE, 2019, 14 (07):
  • [47] Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test
    Sluimer, John
    Goderski, Gabriel
    van den Brink, Sharon
    Broeders, Maaike
    Rahamat-Langendoen, Janette
    Then, Eunice
    Wijsman, Lisa
    Wolters, Femke
    van de Bovenkamp, Jeroen
    Melchers, Willem J. G.
    Meijer, Adam
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (04):
  • [48] RESULTS OF A MULTI-CENTER EVALUATION OF A NEW RAPID TEST FOR DETECTION OF HCV INFECTION USING WHOLE BLOOD, SERUM, PLASMA AND ORAL FLUID
    Lee, S. R.
    Kardos, K.
    Yearwood, G.
    Kurtz, L.
    Roehler, M.
    Feiss, G.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S271 - S271
  • [49] A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer
    Liu, Xin
    Guo, Weijian
    Zhang, Wen
    Yin, Jiliang
    Zhang, Jun
    Zhu, Xiaodong
    Liu, Tianshu
    Chen, Zhiyu
    Wang, Biyun
    Chang, Jianhua
    Lv, Fangfang
    Hong, Xiaonan
    Wang, Huijie
    Wang, Jialei
    Zhao, Xinmin
    Wu, Xianghua
    Li, Jin
    BMC CANCER, 2017, 17
  • [50] A multi-center phase II study of nintedanib as second-line therapy for patients with advanced non-small-cell lung cancer in China
    Dai, Wenxin
    Luo, Bailing
    Wu, Zhiyong
    Chen, Juan
    Feng, Guangqiu
    Guan, Ping
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (10): : 3270 - 3275
12345